Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BASi Appoints COO | Contract Pharma
Breaking News, Promotions & Moves

BASi Appoints COO

Oakley responsible for leading operations at BASi’s three sites in West Lafayette and Evansville, IN, and St. Louis, MO

D. Thomas Oakley has been appointed chief operating officer, BASi. Mr. Oakley will be responsible for leading operations among BASi’s three sites located in West Lafayette and Evansville, IN, and St. Louis, MO.

Mr. Oakley is a senior executive with more than 20 years of strategic and operational experience in the contract research industry. Most recently, he served as chief executive officer of Seventh Wave Laboratories, and joined BASi in July of last year when BASi acquired the operations of Seventh Wave.

Prior to Seventh Wave Laboratories, Mr. Oakley led DTO Associates and served as president and chief operating officer of MPI Research, president and chief executive officer of ChanTest Corp., and president and chief executive officer of Bridge Laboratories. He has also held leadership positions with the Sarah Cannon Research Institute and Covance.

“I have great confidence in Tom and his ability to lead and coordinate operations among our sites,” said Robert Leasure, Jr., BASi’s president and chief executive officer. “We have a talented and highly-capable team of site leaders, and Tom’s vast experience and mentorship is a tremendous asset to us as we continue to unify operations and grow the Company.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters